LJH685

Overview

LJH685 is a potent, ATP-competitive and selective RSK inhibitor, inhibits RSK1 , 2, and 3 biochemical activities with IC 50 s of 6, 5, 4 nM, respectively.

Application

Products | Products > Disease Areas > Lipid Metabolism | Products > Disease Areas > Digestive System Inflammation | Products > Disease Areas > Obesity | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Digestive System Disease | Products > Signaling Pathways > MAPK/ERK Pathway | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Ribosomal S6 Kinase (RSK) | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-19712
• CAS No.: 1627710-50-2
• Molecular Formula: C22H21F2N3O
• Molecular Weight: 381.42
• Purity: 99.64%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 1 mg/mL (2.62 mM); Clear solution
• Availability: In-stock

Source

Original product source